Nephros Inc. (NEPH) 1.1500 $NEPH
Nephros posts lower net loss of USD654,000 for Q2 2014
M2 - Mon Aug 18, 7:36AM CDT
Medical device company Nephros (OTC BB:NEPH) declared on Friday a net loss of USD654,000, or USD0.03 per share for the three months ended 30 June 2014.
Nephros Reports Second Quarter 2014 Financial Results
PR Newswire - Thu Aug 14, 5:17PM CDT
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three and six months ended June 30, 2014.
Nephros Announces FDA 510(k) Submission of DSU-H and SSU-H Ultrafilters to be used to filter EPA quality drinking water to remove microbiological contaminants and waterborne pathogens
PR Newswire - Mon Jun 30, 3:05PM CDT
Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today that it has submitted to the U.S. Food and Drug Administration (FDA), for 510(k) clearance, the DSU-H and SSU-H Ultrafilters to filter Environmental Protection Agency (EPA) quality drinking water to remove microbiological contaminants and waterborne pathogens.
Nephros Reports 2013 Fourth Quarter and Full Year Financial Results
PR Newswire - Fri Mar 28, 3:05PM CDT
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months and full year ended December 31, 2013.
Nephros Announces Completion of Rights Offering
PR Newswire - Mon Mar 24, 3:15PM CDT
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today the successful completion of its rights offering.
Nephros Provides Corporate Update
PR Newswire - Tue Mar 11, 3:20PM CDT
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and a Hemodiafiltration system for the treatment of chronic renal failure patients today provided an update on its operations and strategy.
Nephros and Mar Cor Purification Announce Distribution Agreement
PR Newswire - Tue Mar 11, 3:10PM CDT
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and Mar Cor Purification, a wholly owned subsidiary of Cantel Medical Corp., announced today that the companies have signed a non-exclusive distributor agreement to distribute Nephros's dialysis ultrafilters to U.S. and Canadian dialysis clinics.
MSC Cruises' Easter Spring Fling on MSC Divina
PR Newswire - Tue Mar 04, 8:59AM CST
Looking for a family getaway this Easter? Look no further. MSC Cruises, the only cruise line in which kids sail free year-round, is offering not only special rates but a full week of Easter fun for kids and parents alike.
Nephros and Bellco Extend and Expand License Agreement
PR Newswire - Tue Feb 25, 4:53PM CST
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and Bellco S.r.l., an Italy-based company focused on Dialysis and Extracorporeal Blood Purification, announced today that the companies have signed an amendment to their existing license agreement.
Nephros Announces Rights Offering
PR Newswire - Wed Feb 12, 5:00PM CST
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today that it has commenced its previously disclosed rights offering. On February 12, 2014, the Company will distribute to holders of its common stock and/or warrants one non-transferable subscription right for each share of common stock, and each share of common stock underlying a warrant, held as of January 30, 2014. The rights offering will expire at 5:00 p.m., Eastern Time, on March 14, 2014, if not extended by the Company in its sole discretion.
Nephros Reports First Quarter 2013 Financial Results
PR Newswire - Wed May 08, 3:15PM CDT
Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three months ended March 31, 2013.
Nephros Inc's ultrafilters to be distributed by Chem-Aqua Inc in North America
M2 - Tue Feb 05, 8:34AM CST
Nephros Inc (OTC BB:NEPH) said on Monday that it has entered into a non-exclusive distributor agreement to distribute its innovative ultrafilters in North America.
Nephros and Chem-Aqua Announce Distribution Agreement
PR Newswire - Mon Feb 04, 3:45PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH) and Chem-Aqua, Inc., a wholly owned water treatment subsidiary of NCH Corporation, announced today that the companies have signed a non-exclusive distributor agreement for Chem-Aqua to distribute Nephros's innovative ultrafilters in North America. Chem-Aqua is now beginning launch efforts, including scheduling training sessions and promoting ultrafilters to the hospital market.
Nephros Completes Bridge Financing
PR Newswire - Mon Feb 04, 3:32PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that the company has entered into a bridge loan and security agreement with Lambda Investors LLC, an affiliate of Wexford Capital LP and the company's largest shareholder.
Nephros Receives EUR 600,000 Payment from Bellco S.r.l.
PR Newswire - Tue Jan 15, 3:30PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced that on January 15, 2013, Nephros received the scheduled payment of EUR 600,000 from Bellco S.r.l. under the previously announced license agreement.
Nephros posts lower net loss of USD654,000 for Q2 2014
M2 - Mon Aug 18, 7:36AM CDT
Medical device company Nephros (OTC BB:NEPH) declared on Friday a net loss of USD654,000, or USD0.03 per share for the three months ended 30 June 2014.
Nephros Reports Second Quarter 2014 Financial Results
PR Newswire - Thu Aug 14, 5:17PM CDT
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three and six months ended June 30, 2014.
Nephros Announces FDA 510(k) Submission of DSU-H and SSU-H Ultrafilters to be used to filter EPA quality drinking water to remove microbiological contaminants and waterborne pathogens
PR Newswire - Mon Jun 30, 3:05PM CDT
Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today that it has submitted to the U.S. Food and Drug Administration (FDA), for 510(k) clearance, the DSU-H and SSU-H Ultrafilters to filter Environmental Protection Agency (EPA) quality drinking water to remove microbiological contaminants and waterborne pathogens.
Nephros Reports 2013 Fourth Quarter and Full Year Financial Results
PR Newswire - Fri Mar 28, 3:05PM CDT
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months and full year ended December 31, 2013.
Nephros Announces Completion of Rights Offering
PR Newswire - Mon Mar 24, 3:15PM CDT
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today the successful completion of its rights offering.
Nephros Provides Corporate Update
PR Newswire - Tue Mar 11, 3:20PM CDT
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and a Hemodiafiltration system for the treatment of chronic renal failure patients today provided an update on its operations and strategy.
Nephros and Mar Cor Purification Announce Distribution Agreement
PR Newswire - Tue Mar 11, 3:10PM CDT
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and Mar Cor Purification, a wholly owned subsidiary of Cantel Medical Corp., announced today that the companies have signed a non-exclusive distributor agreement to distribute Nephros's dialysis ultrafilters to U.S. and Canadian dialysis clinics.
MSC Cruises' Easter Spring Fling on MSC Divina
PR Newswire - Tue Mar 04, 8:59AM CST
Looking for a family getaway this Easter? Look no further. MSC Cruises, the only cruise line in which kids sail free year-round, is offering not only special rates but a full week of Easter fun for kids and parents alike.
Nephros and Bellco Extend and Expand License Agreement
PR Newswire - Tue Feb 25, 4:53PM CST
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and Bellco S.r.l., an Italy-based company focused on Dialysis and Extracorporeal Blood Purification, announced today that the companies have signed an amendment to their existing license agreement.
Nephros Announces Rights Offering
PR Newswire - Wed Feb 12, 5:00PM CST
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today that it has commenced its previously disclosed rights offering. On February 12, 2014, the Company will distribute to holders of its common stock and/or warrants one non-transferable subscription right for each share of common stock, and each share of common stock underlying a warrant, held as of January 30, 2014. The rights offering will expire at 5:00 p.m., Eastern Time, on March 14, 2014, if not extended by the Company in its sole discretion.
Nephros Reports First Quarter 2013 Financial Results
PR Newswire - Wed May 08, 3:15PM CDT
Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three months ended March 31, 2013.
Nephros Inc's ultrafilters to be distributed by Chem-Aqua Inc in North America
M2 - Tue Feb 05, 8:34AM CST
Nephros Inc (OTC BB:NEPH) said on Monday that it has entered into a non-exclusive distributor agreement to distribute its innovative ultrafilters in North America.
Nephros and Chem-Aqua Announce Distribution Agreement
PR Newswire - Mon Feb 04, 3:45PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH) and Chem-Aqua, Inc., a wholly owned water treatment subsidiary of NCH Corporation, announced today that the companies have signed a non-exclusive distributor agreement for Chem-Aqua to distribute Nephros's innovative ultrafilters in North America. Chem-Aqua is now beginning launch efforts, including scheduling training sessions and promoting ultrafilters to the hospital market.
Nephros Completes Bridge Financing
PR Newswire - Mon Feb 04, 3:32PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that the company has entered into a bridge loan and security agreement with Lambda Investors LLC, an affiliate of Wexford Capital LP and the company's largest shareholder.
Nephros Receives EUR 600,000 Payment from Bellco S.r.l.
PR Newswire - Tue Jan 15, 3:30PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced that on January 15, 2013, Nephros received the scheduled payment of EUR 600,000 from Bellco S.r.l. under the previously announced license agreement.
